Meningococcal polysaccharide vaccine group A
- Generic Name
- Meningococcal polysaccharide vaccine group A
- Brand Names
- Menquadfi, Menveo, Nimenrix
- Drug Type
- Biotech
- Unique Ingredient Identifier
- 1I86B47NY4
Overview
Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.
Background
Meningococcal group A polysaccharide is group-specific polysaccharide antigens extracted and purified from Neisseria meningitidis serogroup A. N. meningitidis is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup A.
Indication
No indication information available.
Associated Conditions
- Invasive Meningococcal Infection caused by Neisseria meningitidis serogroup A
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.